AROA Business Update Presentation
Filed with ASX · · 10 pages · English
This presentation (Presentation) is dated 3 February 2026 and has been prepared by Aroa Biosurgery Ltd, New Zealand company number 1980577, ARBN 638 867 473 (AROA or the Company). Information in this Presentation The information in this Presentation is of a general background nature, is in summary form and does not purport to be complete. This Presentation has been prepared in conjunction with an
In the deck
Story so far
Earlier from Aroa Biosurgery
- AROA Business Update
- Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
- Aroa Biosurgery H1 FY26 Results
- Appendix 4D and Half Year Report
- September 2025 Quarterly Report and Appendix 4C
Later from Aroa Biosurgery
- Symphony Randomised Control Trial Complete
- ARX FY26 Preliminary Results
- FY26 Appendix 4E and Full Year Results
- FY26 Full Year Results Presentation
- Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery